Beril Kocak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Beril Kocak has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Ayberk Denizli
Marmara University
1 shared publication Betul Yılmaz
Marmara University
1 shared publication- Lara Ozden
Marmara University
1 shared publication - Rezzan Gülhan Aker
Marmara University
1 shared publication - Yakup Gözderesi
İstanbul University-Cerrahpasa, Cerrahpaşa Faculty of Medicine, Department of Child Health and Diseases, Istanbul, Türkiye ";" World Health Organisation, Regional Office for Europe, European Healthy Cities Network, Advisory Committee, Youth Representative (2024-2026)
1 shared publication - Yekta Çulpan
Marmara University
1 shared publication
Latest Publications
- Open Access
- 31 May 2024
- Published by Marmara University in Marmara Medical Journal
- Vol. 37 (2) , 166-177
Effect of methylglyoxal on Parkinson’s disease pathophysiology in the rotenone model
Objective: Type 2 diabetes mellitus patients have been reported to have a higher incidence of Parkinson’s disease. This study aimed to explore the effect of advanced glycation end products precursor methylglyoxal (MGO) on the pathophysiology of Parkinson’s disease in a rotenone model. Materials and Methods: Adult female Wistar rats (n=42) were divided into four groups. Rotenone toxicity was assessed by daily weight measurements and mortality rates. Effect of MGO on blood glucose was evaluated. Locomotor activity, rearing, and rotarod tests were performed to evaluate motor functions, and for neurodegeneration, tyrosine hydroxylase immunoreactivity in the striatum and substantia nigra regions was assessed. Results: The mortality rate was 9% in the rotenone-applied rats. The mean weight, locomotor activity, rearing activity, and longest time spent on a rotarod were lower in the MGO+Rotenone group than in the Control group. Tyrosine hydroxylase immunoreactivity in the striatum rostral to the anterior commissure in the MGO+Rotenone group was lower than that in the Control and MGO groups. The number of tyrosine hydroxylase positive cells in the substantia nigra pars compacta was comparable among the groups. Conclusion: When nigrostriatal degeneration was triggered, MGO was found to worsen motor dysfunction and increase damage to dopaminergic neuron projections.
- 31 May 2024
- Published by Marmara University in Marmara Medical Journal
- Vol. 37 (2) , 166-177
Open AccessEffect of methylglyoxal on Parkinson’s disease pathophysiology in the rotenone model
Objective: Type 2 diabetes mellitus patients have been reported to have a higher incidence of Parkinson’s disease. This study aimed to explore the effect of advanced glycation end products precursor methylglyoxal (MGO) on the pathophysiology of Parkinson’s disease in a rotenone model. Materials and Methods: Adult female Wistar rats (n=42) were divided into four groups. Rotenone toxicity was assessed by daily weight measurements and mortality rates. Effect of MGO on blood glucose was evaluated. Locomotor activity, rearing, and rotarod tests were performed to evaluate motor functions, and for neurodegeneration, tyrosine hydroxylase immunoreactivity in the striatum and substantia nigra regions was assessed. Results: The mortality rate was 9% in the rotenone-applied rats. The mean weight, locomotor activity, rearing activity, and longest time spent on a rotarod were lower in the MGO+Rotenone group than in the Control group. Tyrosine hydroxylase immunoreactivity in the striatum rostral to the anterior commissure in the MGO+Rotenone group was lower than that in the Control and MGO groups. The number of tyrosine hydroxylase positive cells in the substantia nigra pars compacta was comparable among the groups. Conclusion: When nigrostriatal degeneration was triggered, MGO was found to worsen motor dysfunction and increase damage to dopaminergic neuron projections.